Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors Article

cited authors

  • Goldlust, Samuel A.; Cavaliere, Robert; Newton, Herbert B.; Hsu, Meier; DeAngelis, Lisa M.; Batchelor, Tracy T.; Gilbert, Mark R.; Lassman, Andrew B.

authors

Publication Date

  • April 1, 2012

webpage

published in

category

keywords

  • Bevacizumab
  • Glioblastoma
  • Glioma
  • Tyrosine kinase inhibitor
  • Vascular endothelial growth factor

start page

  • 407

end page

  • 411

volume

  • 107

issue

  • 2